Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Sulfur burps on Wegovy result from slowed gastric emptying and increased bacterial fermentation in your gut, producing a rotten egg odor. Most cases can be managed with dietary changes, OTC remedies, meal timing, probiotics, and hydration.
There are several factors to consider before switching medications, so see below for complete details on triggers, management strategies, alternative options, and when to seek professional advice.
Wegovy (semaglutide) has become a popular prescription for long-term weight management. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it helps control appetite and blood sugar. However, some users report sulfur burps—burps that smell like rotten eggs. If you're asking "why does Wegovy cause sulfur burps?" you're not alone. This guide explains the science, offers management tips, and helps you decide whether it's time to consider another medication.
Sulfur burps are belches with a distinct sulfur or "rotten egg" odor. They happen when hydrogen sulfide gas (H₂S) is released in your stomach or intestines, then exhaled. Common triggers include:
Delayed Gastric Emptying
• Wegovy slows stomach emptying to prolong feelings of fullness.
• Slower transit time can allow food to stay in the stomach longer, creating an environment for bacterial fermentation.
Increased Fermentation
• As undigested food lingers, gut bacteria break down proteins and sulfur-containing amino acids.
• The byproduct, H₂S gas, is released and expelled as sulfur burps.
Changes in Gut Motility
• GLP-1 receptor activation can alter gut motility and pH, favoring certain bacteria that produce more H₂S.
Individual Variation
• Your baseline gut flora, diet, and digestive health influence how pronounced sulfur burps become.
Understanding this mechanism answers "why does Wegovy cause sulfur burps?"—it's largely due to slowed digestion and increased bacterial activity.
Clinical trials and real-world reports suggest gastrointestinal side effects (nausea, bloating, diarrhea) are common. Sulfur burps specifically are less frequently documented but still occur for a subset of patients:
If you experience mild burping, it may improve over weeks. Persistent or severe sulfur burps warrant attention.
Before considering a medication change, try these strategies:
Give these measures 2–4 weeks to take effect. Keep a food and symptom diary to track triggers.
If sulfur burps persist or significantly impact your quality of life, it may be time to discuss alternatives. Consider switching if:
Always weigh the risk–benefit profile of each option. Your doctor can help you choose a therapy aligned with your health goals and lifestyle.
Wegovy's benefits for weight management, blood sugar control, and cardiovascular risk reduction can be substantial. Sulfur burps, while unpleasant, are generally not dangerous. Before making a switch:
If your symptoms worsen or you develop any of the following, seek immediate medical attention:
For non-emergency concerns, getting a professional assessment of your symptoms is crucial. Try Ubie's free Medically Approved LLM Symptom Checker to help organize your symptoms and prepare meaningful questions before your doctor's visit.
Sulfur burps on Wegovy stem from delayed gastric emptying and increased bacterial fermentation. In many cases, simple dietary tweaks, OTC remedies, and lifestyle changes can reduce or eliminate this issue. If symptoms persist or affect your quality of life, discuss alternative medications with your healthcare provider. Always speak to a doctor about any serious or life-threatening concerns.
(References)
* Zheng J, et al. Gastrointestinal side effects of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023 Jan 26;14:1107753. doi: 10.3389/fendo.2023.1107753. PMID: 36717141; PMCID: PMC9907106.
* Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33667417.
* Davies MJ, et al. Management of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight management. Obes Rev. 2023 Mar;24 Suppl 1:e13511. doi: 10.1111/obr.13511. Epub 2022 Jan 10. PMID: 35005825.
* Shi Z, et al. Safety and tolerability of once-weekly semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis. Expert Opin Drug Saf. 2020 Jul;19(7):851-863. doi: 10.1080/14740338.2020.1755106. Epub 2020 May 4. PMID: 32338600.
* Khunti K, et al. Patient-reported reasons for discontinuing once-weekly semaglutide in type 2 diabetes in a real-world setting: an analysis of the UK Clinical Practice Research Datalink. Diabetes Obes Metab. 2024 Mar;26(3):1038-1042. doi: 10.1111/dom.15392. Epub 2024 Jan 10. PMID: 38202580.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.